|
PPP3CB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50169999999505E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.3532999999798E-06 |
| Normal-vs-Stage2 |
6.103000E-01 |
| Normal-vs-Stage3 |
2.702000E-03 |
| Normal-vs-Stage4 |
3.604800E-03 |
| Stage1-vs-Stage2 |
2.319900E-02 |
| Stage1-vs-Stage3 |
4.816000E-01 |
| Stage1-vs-Stage4 |
8.225800E-01 |
| Stage2-vs-Stage3 |
1.176990E-01 |
| Stage2-vs-Stage4 |
9.641800E-02 |
| Stage3-vs-Stage4 |
7.684000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.84670000000065E-05 |
| Normal-vs-AfricanAmerican |
9.77979999999823E-05 |
| Normal-vs-Asian |
4.832700E-04 |
| Caucasian-vs-AfricanAmerican |
3.574000E-02 |
| Caucasian-vs-Asian |
4.056400E-01 |
| AfricanAmerican-vs-Asian |
1.421170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.232110E-02 |
| Normal-vs-Female |
1.76289999997969E-06 |
| Male-vs-Female |
1.540810E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.84969999994511E-06 |
| Normal-vs-Age(41-60Yrs) |
2.342100E-03 |
| Normal-vs-Age(61-80Yrs) |
6.478500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.553420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.695900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.878010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.851000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.862600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.936800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.460400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.041800E-01 |
| Classical-VS-Follicular |
5.629500E-04 |
| Classical-VS-Other |
2.729800E-01 |
| Classical-VS-Normal |
5.48190000060345E-08 |
| Tall-VS-Follicular |
6.156500E-02 |
| Tall-VS-Other |
3.504200E-01 |
| Tall-VS-Normal |
6.535100E-03 |
| Follicular-VS-Other |
8.174000E-01 |
| Follicular-VS-Normal |
5.991800E-01 |
| Other-VS-Normal |
4.583200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.376480E-02 |
| Normal-vs-N1 |
8.730100E-02 |
| N0-vs-N1 |
9.754800E-01 |
|
|
